These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 10494572)

  • 1. Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice.
    O'Neill MF; Shaw G
    Psychopharmacology (Berl); 1999 Aug; 145(3):237-50. PubMed ID: 10494572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of D1 and D2 dopamine receptor antagonists and catecholamine depleting agents on the locomotor stimulation induced by dizocilpine in mice.
    Lapin IP; Rogawski MA
    Behav Brain Res; 1995 Oct; 70(2):145-51. PubMed ID: 8561905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB.
    O'Neill MF; Heron-Maxwell CL; Shaw G
    Pharmacol Biochem Behav; 1999 Jun; 63(2):237-43. PubMed ID: 10371652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABA(A) alpha 1 subunit knock-out mice do not show a hyperlocomotor response following amphetamine or cocaine treatment.
    Reynolds DS; O'Meara GF; Newman RJ; Bromidge FA; Atack JR; Whiting PJ; Rosahl TW; Dawson GR
    Neuropharmacology; 2003 Feb; 44(2):190-8. PubMed ID: 12623217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group II metabotropic glutamate receptor antagonists LY341495 and LY366457 increase locomotor activity in mice.
    O'Neill MF; Heron-Maxwell C; Conway MW; Monn JA; Ornstein P
    Neuropharmacology; 2003 Oct; 45(5):565-74. PubMed ID: 12941370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride.
    Martin P; Waters N; Waters S; Carlsson A; Carlsson ML
    Eur J Pharmacol; 1997 Sep; 335(2-3):107-16. PubMed ID: 9369362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic basis for the facilitation of brain stimulation reward by the NMDA receptor antagonist, MK-801.
    Olds ME
    Eur J Pharmacol; 1996 Jun; 306(1-3):23-32. PubMed ID: 8813611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dopaminergic and glutamatergic receptor antagonists on the establishment and expression of conditioned locomotion to cocaine in rats.
    Cervo L; Samanin R
    Brain Res; 1996 Aug; 731(1-2):31-8. PubMed ID: 8883851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MK-801 and amphetamine result in dissociable profiles of cognitive impairment in a rodent paired associates learning task with relevance for schizophrenia.
    Talpos J; Aerts N; Waddell J; Steckler T
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):3911-20. PubMed ID: 25902874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of cataleptic responses to dopamine receptor antagonists after withdrawal from chronic cocaine or cocaine plus dopamine antagonist administration.
    Ushijima I; Mizuki Y; Suetsugi M; Akimoto T; Yamada M
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):709-21. PubMed ID: 9682282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of D2-like dopamine receptors in the locomotor stimulant effects of cocaine in mice.
    Chausmer AL; Katz JL
    Psychopharmacology (Berl); 2001 Apr; 155(1):69-77. PubMed ID: 11374338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats.
    Barrett AC; Miller JR; Dohrmann JM; Caine SB
    Neuropharmacology; 2004; 47 Suppl 1():256-73. PubMed ID: 15464142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice.
    Mele A; Castellano C; Felici A; Cabib S; Caccia S; Oliverio A
    Eur J Pharmacol; 1996 Jul; 308(1):1-12. PubMed ID: 8836626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats.
    Ouagazzal A; Nieoullon A; Amalric M
    Psychopharmacology (Berl); 1993; 111(4):427-34. PubMed ID: 7870984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of dopamine receptor subtypes in the discriminative stimulus effects of amphetamine and cocaine in rats.
    Filip M; Przegaliński E
    Pol J Pharmacol; 1997; 49(1):21-30. PubMed ID: 9431548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on electroencephalogram (EEG) in rats suggest that moderate doses of cocaine or d-amphetamine activate D1 rather than D2 receptors.
    Ferger B; Kropf W; Kuschinsky K
    Psychopharmacology (Berl); 1994 Mar; 114(2):297-308. PubMed ID: 7838923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of AMPA receptor positive modulators on amphetamine- and dizocilpine-induced locomotion.
    Vanover KE
    Eur J Pharmacol; 1997 Aug; 332(2):115-9. PubMed ID: 9286612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of NMDA and dopamine D1 and D2 receptors in the acquisition and expression of flavor preferences conditioned by oral glucose in rats.
    Dela Cruz JA; Coke T; Icaza-Cukali D; Khalifa N; Bodnar RJ
    Neurobiol Learn Mem; 2014 Oct; 114():223-30. PubMed ID: 25065714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral effects of cocaine: interactions with D1 dopaminergic antagonists and agonists in mice and squirrel monkeys.
    Katz JL; Kopajtic TA; Myers KA; Mitkus RJ; Chider M
    J Pharmacol Exp Ther; 1999 Oct; 291(1):265-79. PubMed ID: 10490913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors.
    Houchi H; Babovic D; Pierrefiche O; Ledent C; Daoust M; Naassila M
    Neuropsychopharmacology; 2005 Feb; 30(2):339-49. PubMed ID: 15383833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.